Series A Financing For Annovation Includes Potential Buyout By TMC
This article was originally published in The Pink Sheet Daily
Executive Summary
The newest company created under the Atlas Venture Development Corp. model, Annovation, will develop a next-generation anesthetic through proof-of-concept, with investor The Medicines Co. holding an option to acquire the new company.